Hydrocephalus Market Research Report - Forecast till 2027

Hydrocephalus Market Research Report: Information by Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus), Diagnostic (CT scan – head, MRI, Head Ultrasound), Treatment (Surgery – Shunt Insertion, Ventriculostomy, Medication), End User (Hospitals & Clinics, Diagnostic Centres, Academic Institutions and Research Organizations) and Region - Forecast till 2027

ID: MRFR/MED/1187-CR | August 2019 | Region: Global | 139 pages         

Hydrocephalus Market

Hydrocephalus Market is expected to register a CAGR of 5.5 % and was valued at USD 2,103.34 Million.

Segmentation

By Type Congenital Hydrocephalus Acquired Hydrocephalus Normal-Pressure Hydrocephalus Ex-Vacuo Hydrocephalus
Diagnostic CT scan – head MRI Head Ultrasound
Treatment Surgery – Shunt Insertion Ventriculostomy Medication
End User Hospitals & Clinics Diagnostic Centres Academic Institutions and Research Organizations

Key Players

  • DePuy Synthes
  • Boston Neurosciences
  • Medtronic Plc
  • Integra LifeSciences Corporation
  • Spiegelberg GmbH & Co. KG
  • RAUMEDIC Inc
  • Sophysa SA
  • Terumo Corporation
  • Natus Medical Incorporated
  • Johnson & Johnson Services Inc
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • Tokibo Co.
  • Ltd
  • HLL Lifecare Limited and others

Drivers

  • Increasing prevalence of hydrocephalus
  • High incidence of traumatic brain injuries
  • Constant evaluation of various techniques
Speak to Analyst Request a Free Sample

Hydrocephalus Market Overview


The Hydrocephalus Market Size to grow at a CAGR of 4.4% By 2023. The whole Hydrocephalus Market is expected to gain in the forecast period. Although the growth rate is not a double-digit one, the Market will not see stagnancy. The Market is a significant one because of the importance Hydrocephalus condition gets in today’s healthcare. However, the market is looking at different conditions. The present market scenario and future projections of the Market are discussed in this Market Outlook.


Hydrocephalus is a neural ailment that arises when CSF accumulates within the cranial cavities of a person. It is a very serious ailment that should not be neglected in any case. The accumulation of CSF leads to enlargement in vein size. This, in turn, causes the brain of the patient to swell unnaturally. This accumulation of CSF leads to damage to brain tissues. The brain and spinal tissues suffer considerable damage if Hydrocephalus is not treated properly. Hydrocephalus is a rare condition, but it arises in infants and adults over the age of 60. During these ages, the brain and neural systems are invulnerable systems.


Hydrocephalus at any age can be very dangerous for the patient. Its consequences range from sleepiness, vomiting to seizures and imbalance. While it can happen in people due to many reasons, the cause of obstruction in normal CSF flow is very common. If the person has suffered some internal bleeding or has a tumor in the brain, the chances of Hydrocephalus are high. Another cause is the overproduction of CSF which topples the balance of CSF flow in the nervous system. This can also lead to Hydrocephalus. However, overproduction is very rare.


No matter how rare the condition is, it is painful and dangerous. Thus, it needs immediate treatment. Therefore, the Hydrocephalus Industry plays a huge role in modern healthcare.


Cumulative Growth Analysis


The Hydrocephalus Market is growing at a healthy pace and is expected to be USD 1,348.00 million in 2017, at a CAGR of 4.4% during the forecast period 2018-2023. The growth rate of the Market may not be as high as a double-digit CAGR, but it is enough to keep the market moving towards better Market trends. As the population becomes more self-aware about Hydrocephalus and its treatment, the Hydrocephalus Industry Trends will turn positive.


COVID 19 Analysis


The COVID 19 pandemic has affected every industrial vertical, and the Hydrocephalus Industry is no stranger to the impact of COVID 19. The Hydrocephalus Market is facing newer challenges and restraints under the impact of the COVID 19 pandemic. The COVID 19 pandemic has created supply chain challenges where there were none before. The Hydrocephalus Industry is struggling to supply hydrocephalic treatment approaches to the global patient population.


The unavailability of skilled human resources in the neurological sector is also affecting the Market in the post-pandemic phase. Similarly, the shutdown of neurological wards and clinics is also a negative Hydrocephalus Market Trend. The Market, therefore, does not show a high rate of growth in the pandemic and post-pandemic years. The neurological healthcare sector is also running out of resources as most of the resources are directed towards COVID 19 treatment. In such circumstances, the Market does not advance at a healthy rate. The overall impact of the COVID 19 pandemic has been unfavorable for the Hydrocephalus Industry.


Market Dynamics


The key drivers of the market


The increased incidence of Hydrocephalus in people and infants is a major driver of the Hydrocephalus Industry. According to an academic study in 2019, the incidence of pediatric Hydrocephalus is 88 out of 100,000 births globally. This is an increased incidence of Hydrocephalus in infants. On the other hand, the increase in life-threatening accidents and brain injuries in adults is also driving the growth of the Hydrocephalus Industry. The increased prevalence of the two indicators is a favorable one for the Hydrocephalus Market.


Significant opportunities


Besides the increased prevalence of induced Hydrocephalus, the increase in the incidence of neurological disorders due to lifestyle diseases is also an opportunity for the Hydrocephalus Market Size to increase its product portfolio and application. The incidence of congenital defects in the present generation is also increasing. This produces another window of opportunity for expanding the Hydrocephalus Industry Size. All these factors may seem dreary, but they are instrumental in presenting new opportunities to the Market for Hydrocephalus Industry Growth. Another opportunity for Market Growth is the use of advanced surgical techniques with the help of valves. When people become aware of the possible treatment of Hydrocephalus, it will only drive the growth of the Market further.


Market Restraints


There are some restraints that limit the Hydrocephalus Industry Growth in the long run. These restraints are no different from the usual restraints that exist in the healthcare sector. With advanced treatment procedures, there is always a chance that an implant or treatment approach will lead to a further complication. In the Hydrocephalus Industry, too, the shunts used to relieve pressure from the brain may lead to infections and malfunctions. This causes a decline in the Hydrocephalus Industry share worldwide. Another restraint is the presence of irreversible brain damage due to accidents.


Market Challenges


The market challenges are the ones that can be solved and lead to more growth than limitation. The major challenge, according to Hydrocephalus Market analysis, is the need for research and development of advanced equipment and treatment in the Hydrocephalus Industry. There is a great scope to create an advanced approach to treating Hydrocephalus. However, this needs joint effort from the key players of the Hydrocephalus Industry. When the key players of the Market invest in the advancement of Hydrocephalic treatments, the Market will also progress.


Segment Overview


The Hydrocephalus Market Analysis points at the different segments of the Hydrocephalus Market. The Hydrocephalus Industry divides into categories based on type, diagnosis, treatment, and end-user.


By Type- By type, the primary segments of the market are congenital Hydrocephalus and acquired Hydrocephalus.


By diagnostic- By the way, Hydrocephalus is diagnosed, the Market divides into MRI, CT Scan, and head ultrasound.


By surgery- By the surgery that is used to cure the condition, the market disperses into shunt insertion procedure, ventriculostomy, and medication to balance CSF.


By end-user- The major end-user for the Market are hospitals, clinics, and diagnostics centers.


Regional Analysis


On the basis of the regional analysis of the Hydrocephalus Market, the American region, including North America and South America, will be the major regional markets for Hydrocephalus treatments. The companies that create Hydrocephalus treatment devices dominate the North American region. This then translates into regional dominance for the North American region. There is much interest in the research and development of Hydrocephalus treatment in the region. This is especially true for the USA. However, the European regional market will be the second-largest market for Hydrocephalus treatments. Hydrocephalus in infancy will drive growth in the region.


Competitive landscape 


There are many key players in the Market that dominate the competitive landscape for the market. 


The key players of the Hydrocephalus Market segment are as follows. 



  • DePuy Synthes

  • Boston Neurosciences

  • Medtronic Plc

  • Integra Life Sciences Corporation

  • Spiegelberg GmbH & Co. KG

  • RAUMEDIC Inc

  • Sophysa SA

  • Terumo Corporation

  • Natus Medical Incorporated

  • Johnson & Johnson Services Inc


Recent Developments


The key competitors of the Hydrocephalus Market are investing in research and development of new, advanced Hydrocephalus treatment approaches. The Hydrocephalus Market forecast also predicts that the key players also take up a lot of mergers, collaborations, and acquisitions to achieve a common goal of supporting the Hydrocephalus Market collectively. The research and development in the area of Hydrocephalus treatments will benefit all the major players of the Hydrocephalus Market.


Report Overview 


The Hydrocephalus Market Outlook or overview is as follows:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This report focuses on the Hydrocephalus Market and its trends. It highlights the key drivers, significant opportunities for growth and presents market challenges of the Hydrocephalus Industry. Thirdly, it discusses the segmentation of the Hydrocephalus Industry over various benchmarks and segments. Additionally, the Hydrocephalus Industry Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Hydrocephalus Industry Forecast for the readers. 



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 1,348.00 million
  • 2027: Significant Value
  •   CAGR   4.4% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Diagnostic, Treatment, End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   DePuy Synthes, Boston Neurosciences, Medtronic Plc, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc, Sophysa SA, Terumo Corporation, Natus Medical Incorporated, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, Tokibo Co., Ltd, HLL Lifecare Limited and others
      Key Market Opportunities   Investments in development of new shunts
      Key Market Drivers

  • Increasing prevalence of hydrocephalus
  • High incidence of traumatic brain injuries
  • Constant evaluation of various techniques


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The hydrocephalus market valuation was USD 1348 million in 2017.

    The hydrocephalus market projected CAGR would be 4.4% for the forecast period.

    The end users are diagnostic centers, hospitals & clinics, academic institutions & research organizations.

    The segments are MRI, CT scan – head, and head ultrasound.

    America is leading the hydrocephalus market.

    Hydrocephalus Market: Competitive Landscape


    The prominent players in the global hydrocephalus market are Medtronic Plc (PS Medical), Codman (Johnson & Johnson), Integra LifeSciences Corporation, B. Braun Melsungen AG, DePuy Synthes, Christoph Miethke GmbH & Co. KG, Spiegelberg GmbH & Co. KG and others.


    Medtronic Plc (PS Medical) is the holds the largest share for the global hydrocephalus market in 2017. The company is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. Medtronic Plc with Covidien has accelerated and advanced its ability to create meaningful innovations for hospitals, health systems, and healthcare providers so that it can deliver the best care possible to patients and their families around the world.


    Codman (Johnson & Johnson) holds second position in terms of market share in the global hydrocephalus market in 2017. The company manufactures medical devices for various specialties, such as orthopedics, cardiovascular diseases, and many others. J&J Services has acquired and merged with various other companies to expand its portfolio of endoscopic devices. Ethicon, a subsidiary of J&J offers a broad range of suture needle products


    Integra LifeSciences Corporation holds third position in terms of market share in the global hydrocephalus market in 2017. The company is an international leader in medical technology. The key focus of the company is to provide patients with a high level of satisfaction. The company also provides and operates innovative solutions in the field of orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. In the US, Integra LifeSciences Corporation is one of the leading players for providing surgical devices and instruments to various hospitals, surgery centers, physicians, and dental offices.



    1. Braun Melsungen AG is a leading healthcare supplier. The company provides its products for hospitals, surgeries, private practices (medical care and doctors´ offices), and extracorporeal blood treatments. The company’s product segments include clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopedics, spine, and wound care, among others. The company operates in four major divisions, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum. With these four divisions, the company has a wide range of products with about 5,000 products, out of which 95% of the products are manufactured by the company. Geographically the company operates in 64 countries in regions such as Europe, Asia-Pacific, Latin America, and the Middle East and Africa.


    DePuy Synthes is a contract manufacturing organization of softgel capsules and supplies to the nutritional supplement market. It operates a Good Manufacturing Practices (GMP) facility licensed by the UK Medicines & Healthcare products Regulatory Authority (MHRA). EuroCaps is a part of DCC Health and Beauty Solutions, a subsidiary of DCC Healthcare.


    Medtronic Plc (PS Medical), and Codman (Johnson & Johnson) are the major companies for hydrocephalus operating on a global scale. The lower market share of Spiegelberg GmbH & Co. KG can be attributed to fewer products offering, as compared to other major players. Key players such as Christoph Miethke GmbH & Co. KG, RAUMEDIC Inc., Natus Medical Incorporated, Terumo Corporation, Boston Neurosciences increase the level of competition in the global hydrocephalus market, as these companies are expected to expand their product portfolios, with the help of other business units, to increase their market share.